Pan American Health Organization Strategic Fund. Summary
Loading...
Cite
Pan American Health Organization Strategic Fund. Summary. (2022). [Information kit (folder, banner, brochure)]. OPAS. https://iris.paho.org/handle/10665.2/55677
Files
English; 4 pages (updated 4 Feb 2022)
Date
2022
Document Number
PAHO/HSS/SF/22-0001
ISBN
eISBN
ISSN
DOI
Authors
Description
This publication provides advocacy material aimed at policymakers and decision-makers external to PAHO. The publication describes what the Strategic Fund is, what makes it different from other regional mechanisms or other agencies, and informs the reader about the people who benefitted from the Strategic Fund.
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item Fonds stratégique de l’Organisation panaméricaine de la Santé. Résumé(PAHO, 2022)Cette publication est un outil de plaidoyer destiné aux responsables politiques et aux décideurs externes à l'OPS. La publication décrit ce qu'est le Fonds stratégique, ce qui le différencie des autres mécanismes régionaux ou des autres agences et informe le lecteur sur les personnes qui ont bénéficié du Fonds stratégique.Item Strategic Fund. Access to high-quality medicines and health technologies in the Americas. Annual Report 2016(PAHO, 2017)[Preface] Access to medicines and other health supplies is essential if we are to achieve universal access to health and universal health coverage. Rising costs, lack of availability, and substandard quality of medicines constitute some of the challenges that our Member States face in ensuring equitable access to medical products throughout health systems and services. The Strategic Fund was created in 2000 by the Pan American Health Organization (PAHO) as a mechanism to improve equitable access to safe, efficacious, and quality medicines and supplies in the Americas. Through the Strategic Fund, participating countries join together in solidarity to pool needs and collectively procure quality health supplies at affordable prices. The achievements of 2016 reflect the advances that have been made collectively by our Member States as they continue to expand access to medicines and other essential supplies, and move progressively towards the achievement of universal health.Item What is the Strategic Fund?(PAHO, 2022)This advocacy brief provides high-level, clear information for the general public on the PAHO Strategic Fund for Essential Medicines and Supplies.Item Strategic Fund Annual Report 2019. Improving Access to Quality Medicines and Health Technologies in the Americas(PAHO, 2020)In 2000, the Pan American Health Organization (PAHO) established the Strategic Fund to improve access to safe, efficacious, and high-quality medicines and other health supplies. This increased access would inevitably strengthen the efficiency and sustainability of public health systems in the Americas. The Strategic Fund is a regional technical cooperation mechanism for the pooled procurement of essential medicines and strategic health supplies. The Fund contributes to countries’ commitments to achieving the Sustainable Development Goals (SDGs) by facilitating access to affordable, high-quality medicines, and other health technologies. The 2019 Annual Report of the PAHO Strategic Fund details the progress made possible through close technical cooperation. Because of the Fund’s effectiveness in facilitating enhanced supply chain management of critical public health supplies, we have signed participating agreements with 34 countries and territories and developed new partnerships with pivotal health agencies. Procurement volume through the PAHO Strategic Fund has increased by 81% compared to 2018, proving the Fund is an important mechanism to achieve health for all. Responding to the increasing needs of Member States, the Strategic Fund has negotiated long-term agreements for WHO-prequalified HIV/AIDS and cancer treatments at substantially reduced prices, spearheaded a joint initiative for cardiovascular diseases, and strengthened in-country capacity-building for demand forecasting and inventory management. These initiatives have directly provided treatments for over 7.5 million people in 2018 and 2019 and will enable millions more to access high-quality medicines, diagnostic kits and equipment, vector control materials, and other health supplies and technologies that remain affordable in the coming years.Item Annual Report of the Director of the Pan American Sanitary Bureau 2021. Working through the COVID‑19 Pandemic. (Official Document;364)(PAHO, 2021)The Director’s 2021 annual report on the work of the Pan American Sanitary Bureau (the Bureau), Regional Office for the Americas of the World Health Organization, highlights the technical cooperation undertaken by the Bureau during the period from July 2020 to June 2021, within the framework of the 2020–2025 Strategic Plan of the Pan American Health Organization (PAHO). The theme of the report is: Working through the COVID-19 Pandemic. The period covered has been the most challenging ever encountered by PAHO. The pandemic, through its devastating health and economic consequences, has severely impacted people’s lives and livelihoods and disrupted countries, societies, economies, and their development. This has occurred in conjunction with the inevitable challenges on the road to equitable, sustainable development and the achievement of the 2030 Sustainable Development Goals and the objectives of the Sustainable Health Agenda for the Americas 2018–2030. The publication opens with a preface by the Director of PASB, a concise executive summary, and a brief introduction. It then presents a comprehensive review of PAHO’s technical cooperation, and of the Bureau’s institutional and strengthening functions. The report highlights achievements, challenges, and lessons learned as the Bureau undertook technical cooperation with PAHO Member States at national, subregional, and regional levels within the context of the COVID-19 pandemic, working with traditional and new partners to find equitable solutions for emerging and persisting health issues in the Region of the Americas. It also looks ahead, analyzing those opportunities brought to light by the COVID-19 experience for strengthening PAHO’s promotion of and contribution to equity and progressive realization of the right to health. Moreover, it indicates how the Bureau, with the concurrence and guidance of Member States, and in collaboration with partners, will take advantage of such opportunities. This report is complemented by the Financial Report of the Director, and the Report of the External Auditor for the year 2020.